title: Response to Comment on: Satoh-Asahara et al. Highly purified eicosapentaenoic acid increases interleukin-10 levels of peripheral blood monocytes in obese patients with dyslipidemia. Diabetes Care 2012;35:2631-2639.
authors.forename: Noriko
authors.initials: N
authors.lastname: Satoh-Asahara
authors.forename: Akira
authors.initials: A
authors.lastname: Shimatsu
authors.forename: Hiromichi
authors.initials: H
authors.lastname: Wada
authors.forename: Takayoshi
authors.initials: T
authors.lastname: Suganami
authors.forename: Koji
authors.initials: K
authors.lastname: Hasegawa
authors.forename: Yoshihiro
authors.initials: Y
authors.lastname: Ogawa
mesh_terms: D050171:Dyslipidemias / Q000188:drug therapy* / Q000378:metabolism*; D015118:Eicosapentaenoic Acid / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D016753:Interleukin-10 / Q000378:metabolism*; D007963:Leukocytes, Mononuclear / Q000378:metabolism*; D008297:Male; D009765:Obesity / Q000188:drug therapy* / Q000378:metabolism*
chemical_list: D016753:Interleukin-10; D015118:Eicosapentaenoic Acid